Viemed Healthcare (NASDAQ:VMD) Stock Price Up 1.2% – Time to Buy?

Shares of Viemed Healthcare, Inc. (NASDAQ:VMD) shot up 1.2% during trading on Thursday . The stock traded as high as $10.08 and last traded at $10.01. 228,480 shares traded hands during mid-day trading, a decline of 10% from the average session volume of 254,562 shares. The stock had previously closed at $9.89.

Analyst Ratings Changes

Separately, Wall Street Zen upgraded shares of Viemed Healthcare from a “buy” rating to a “strong-buy” rating in a research report on Saturday, February 14th. Two research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the company currently has a consensus rating of “Hold”.

Viemed Healthcare Price Performance

The company has a quick ratio of 1.10, a current ratio of 1.22 and a debt-to-equity ratio of 0.06. The stock’s 50-day simple moving average is $9.50 and its two-hundred day simple moving average is $8.29. The company has a market capitalization of $383.78 million, a price-to-earnings ratio of 27.05 and a beta of 1.15.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings results on Tuesday, May 5th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.03). Viemed Healthcare had a return on equity of 10.52% and a net margin of 5.20%.The company had revenue of $75.41 million for the quarter, compared to analyst estimates of $74.40 million. Equities research analysts predict that Viemed Healthcare, Inc. will post 0.44 earnings per share for the current year.

Insider Buying and Selling at Viemed Healthcare

In related news, President Michael Moore sold 65,000 shares of the company’s stock in a transaction dated Friday, March 20th. The shares were sold at an average price of $8.77, for a total transaction of $570,050.00. Following the completion of the transaction, the president owned 1,585,812 shares in the company, valued at $13,907,571.24. This represents a 3.94% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In the last three months, insiders have sold 136,802 shares of company stock worth $1,237,976. 20.00% of the stock is owned by corporate insiders.

Institutional Trading of Viemed Healthcare

Several large investors have recently bought and sold shares of the business. Wasatch Advisors LP grew its stake in Viemed Healthcare by 18.4% during the 2nd quarter. Wasatch Advisors LP now owns 1,546,010 shares of the company’s stock valued at $10,683,000 after acquiring an additional 240,346 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in Viemed Healthcare by 3.6% during the 4th quarter. Goldman Sachs Group Inc. now owns 1,447,033 shares of the company’s stock valued at $10,751,000 after acquiring an additional 49,962 shares in the last quarter. Geode Capital Management LLC grew its stake in Viemed Healthcare by 2.0% during the 2nd quarter. Geode Capital Management LLC now owns 798,515 shares of the company’s stock valued at $5,519,000 after acquiring an additional 15,353 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its stake in Viemed Healthcare by 101.9% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 711,186 shares of the company’s stock valued at $6,550,000 after acquiring an additional 358,863 shares in the last quarter. Finally, State Street Corp grew its stake in Viemed Healthcare by 1.7% during the 4th quarter. State Street Corp now owns 675,190 shares of the company’s stock valued at $5,017,000 after acquiring an additional 11,385 shares in the last quarter. Hedge funds and other institutional investors own 74.24% of the company’s stock.

Viemed Healthcare Company Profile

Viemed Healthcare, Inc (NASDAQ: VMD) is a provider of home-based respiratory therapy services, specializing in the management of patients requiring long-term mechanical ventilation and pulmonary support. The company’s offerings encompass invasive and noninvasive ventilation, airway clearance therapies, cough assist devices, and supplemental oxygen. Viemed combines durable medical equipment with clinical care, delivering tailored respiratory treatment plans that are overseen by licensed respiratory therapists and registered nurses.

Founded in the early 2010s and headquartered in Birmingham, Alabama, Viemed has grown its footprint to serve patients across multiple states in the United States.